Research on GLP-1 for metabolic syndrome and early intervention Chicago
Numbness or tingling sensations in the hands and feet
36 IkedaY.KamagataM.HiraoM.YasudaS.IwamiS.SasakiH.et al (2018)
343 Other ongoing studies, such as the NRG-BR007 DEBRA trial (NCT04852887), also incorporate the Oncotype DX 21-gene recurrence score, whereas the PRECISION (NCT02653755) and EXPERT (NCT02889874) studies employ PAM50 testing
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of alzheimers disease pathology
Cardiovascular or respiratory disease, renal or hepatic impairment, diabetes, Helicobacter pylori infection, rheumatoid arthritis, and hypertension are also associated with increased risk